As molecular therapy continues to grow, unanticipated challenges may arise, requiring the institution's therapeutic team to reevaluate its therapeutic protocol to identify and address potential situations and challenges that may occur. This practical pointer will focus on the novel prostate cancer therapy Pluvicto (Lu-vipivotide tetraxetan) and 2 unique situations and challenges of treating patients at the Theranostic Center at Carilion Clinic, an outpatient facility dedicated to targeted molecular therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2967/jnmt.123.266482 | DOI Listing |
Publication Analysis
Top Keywords
molecular therapy
8
situations challenges
8
critical challenges
4
challenges pluvicto
4
therapy
4
pluvicto therapy
4
therapy incontinent
4
incontinent anticoagulated
4
anticoagulated patients
4
patients molecular
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!